Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy.

Richman DD, Havlir D, Corbeil J, Looney D, Ignacio C, Spector SA, Sullivan J, Cheeseman S, Barringer K, Pauletti D, et al.

J Virol. 1994 Mar;68(3):1660-6.

2.

The genetic and functional basis of HIV-1 resistance to nonnucleoside reverse transcriptase inhibitors.

Emini EA, Byrnes VW, Condra JH, Schleif WA, Sardana VV.

Arch Virol Suppl. 1994;9:11-7. Review.

PMID:
7518271
3.

Emergence of mutant HIV reverse transcriptase conferring resistance to AZT.

Richman DD.

J Enzyme Inhib. 1992;6(1):55-64. Review. No abstract available.

PMID:
1285303
4.

Current clinical experience with nevirapine for HIV infection.

Carr A, Cooper DA.

Adv Exp Med Biol. 1996;394:299-304. Review.

PMID:
8815694
5.

A novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase.

Merluzzi VJ, Rosenthal AS.

Adv Exp Med Biol. 1992;312:89-94. Review. No abstract available.

PMID:
1381140
6.

Clinical experience with non-nucleoside reverse transcriptase inhibitors: L-697,661 and nevirapine.

Kilby JM, Saag MS.

Adv Exp Med Biol. 1996;394:291-8. Review. No abstract available.

PMID:
8815693
7.

Resistance to anti-human immunodeficiency virus therapeutic agents.

Emini EA.

Adv Exp Med Biol. 1995;390:187-95. Review. No abstract available.

PMID:
8718613
8.

In vivo selection of HIV-1 variants with reduced susceptibility to the protease inhibitor L-735,524 and related compounds.

Emini EA, Schleif WA, Deutsch P, Condra JH.

Adv Exp Med Biol. 1996;394:327-31. Review.

PMID:
8815697
9.

Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents.

Richman DD.

Antimicrob Agents Chemother. 1993 Jun;37(6):1207-13. Review. No abstract available.

10.

Selection of zidovudine-resistant variants of human immunodeficiency virus by therapy.

Richman DD.

Curr Top Microbiol Immunol. 1992;176:131-42. Review. No abstract available.

PMID:
1600750

Supplemental Content

Support Center